Literature DB >> 19123744

Optimal use of Myco/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteria.

James E Kirby1, Meghan Delaney, Qinfang Qian, Howard S Gold.   

Abstract

CONTEXT: The optimal use of dedicated fungal and mycobacterial blood culture bottles, such as the BACTEC Myco/F Lytic bottle, has not been well defined in clinical practice.
OBJECTIVES: To compare the performance of Myco/F Lytic and standard blood culture in clinical practice in an urban tertiary care hospital setting and to implement a strategy for optimal use of Myco/F Lytic culture. DATA SOURCES: Retrospective review of laboratory records.
RESULTS: Myco/F Lytic culture did not increase detection of yeasts. Nor did it decrease time to detection except for Candida glabrata, where mean time to positivity dropped from 2.6 +/- 1.1 days in standard to 1.8 +/- 0.8 days in Myco/F Lytic culture. Therefore, an algorithm was developed in which Myco/F Lytic culture was reserved primarily for detection of mycobacteria in patients with severely depressed CD4 counts. Implementation of this algorithm led to a sustained 3-fold reduction in Myco/F Lytic blood culture usage.
CONCLUSIONS: Retrospective analysis suggests substantial clinical equivalence of standard blood and Myco/F Lytic culture for detection of yeast. A multifaceted educational approach based on this data led to a sustained change in physician ordering practices and more cost-effective use of resources.

Entities:  

Mesh:

Year:  2009        PMID: 19123744     DOI: 10.5858/133.1.93

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Comparison of the Bactec Fx Plus, Mycosis IC/F, Mycosis/F Lytic blood culture media and the BacT/Alert 3D FA media for detection of Candida species in seeded blood culture specimens containing therapeutic peak levels of fluconazole.

Authors:  Dong Wook Jekarl; So-Young Lee; Seungok Lee; Yeon-Joon Park; Jehoon Lee; Sun Mi Baek; Yeon Ju An; Sun Myeong Ock; Mi-Kyung Lee
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

2.  ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.

Authors:  Ignacio Martin-Loeches; Massimo Antonelli; Manuel Cuenca-Estrella; George Dimopoulos; Sharon Einav; Jan J De Waele; Jose Garnacho-Montero; Souha S Kanj; Flavia R Machado; Philippe Montravers; Yasser Sakr; Maurizio Sanguinetti; Jean-Francois Timsit; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440

3.  Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2).

Authors:  Sevtap Arıkan Akdağlı; Alpay Azap; Figen Başaran Demirkazık; Beyza Ener; Sibel Aşcıoğlu Hayran; Özlem Özdemir Kumbasar; Gökhan Metan; Zekaver Odabaşı; Ömrüm Uzun; Hamdi Akan
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

4.  A dedicated fungal culture medium is useful in the diagnosis of fungemia: a retrospective cross-sectional study.

Authors:  Shuwei Zheng; Tong Yong Ng; Huihua Li; Ai Ling Tan; Thuan Tong Tan; Ban Hock Tan
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 5.  Diagnosis of active tuberculosis disease: From microscopy to molecular techniques.

Authors:  Adam J Caulfield; Nancy L Wengenack
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-05-25

6.  Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis.

Authors:  Frederic Lamoth; Cornelius J Clancy; Frederic Tissot; Kevin Squires; Philippe Eggimann; Ursula Flückiger; Martin Siegemund; Christina Orasch; Stefan Zimmerli; Thierry Calandra; Oscar Marchetti; Minh H Nguyen; Pierre-Yves Bochud
Journal:  Open Forum Infect Dis       Date:  2020-02-27       Impact factor: 3.835

Review 7.  Utilization management in microbiology.

Authors:  John A Branda; Kent Lewandrowski
Journal:  Clin Chim Acta       Date:  2013-09-29       Impact factor: 3.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.